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Abstract
The	 intervertebral	 disc	 (IVD)	 degeneration	 is	 thought	 to	 be	 closely	 related	 to	 in-
growth	of	new	blood	vessels.	However,	the	impact	of	anti-angiogenic	factors	in	the	
maintenance of IVD avascularity remains unknown. Tenomodulin (Tnmd)	 is	 a	 ten-
don/ligament-specific	marker	and	anti-angiogenic	factor	with	abundant	expression	
in the IVD. It is still unclear whether Tnmd contributes to the maintenance of IVD 
homeostasis,	acting	to	inhibit	vascular	ingrowth	into	this	normally	avascular	tissue.	
Herein,	we	investigated	whether	IVD	degeneration	could	be	induced	spontaneously	
by the absence of Tnmd.	Our	 results	 showed	that	Tnmd	was	expressed	 in	an	age-
dependent	manner	primarily	in	the	outer	annulus	fibrous	(OAF)	and	it	was	downregu-
lated at 6 months of age corresponding to the early IVD degeneration stage in mice. 
Tnmd knockout (Tnmd−/−)	mice	exhibited	more	rapid	progression	of	age-related	IVD	
degeneration.	 These	 signs	 include	 smaller	 collagen	 fibril	 diameter,	markedly	 lower	
compressive	stiffness,	reduced	multiple	IVD-	and	tendon/ligament-related	gene	ex-
pression,	induced	angiogenesis,	and	macrophage	infiltration	in	OAF,	as	well	as	more	
hypertrophic-like	chondrocytes	in	the	nucleus	pulposus.	In	addition,	Tnmd and chon-
dromodulin I (Chm1,	 the	only	homologous	gene	 to	Tnmd)	 double	knockout	 (Tnmd−
/−Chm1−/−)	mice	displayed	not	only	accelerated	 IVD	degeneration,	but	also	ectopic	
bone	formation	of	IVD.	Lastly,	the	absence	of	Tnmd	in	OAF-derived	cells	promoted	
p65	and	matrix	metalloproteinases	upregulation,	and	increased	migratory	capacity	of	
human	umbilical	vein	endothelial	cells.	In	sum,	our	data	provide	clear	evidences	that	
Tnmd acts as an angiogenic inhibitor in the IVD homeostasis and protects against 
age-related	 IVD	degeneration.	 Targeting	Tnmd	may	 represent	 a	 novel	 therapeutic	
strategy	for	attenuating	age-related	IVD	degeneration.
K E Y W O R D S
angiogenesis,	annulus	fibrous,	intervertebral	disc	degeneration,	knockout	mice,	nucleus	
pulposus,	tenomodulin
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1  | INTRODUC TION
Intervertebral	disc	(IVD)	degeneration	is	a	common	condition	and	is	
thought	to	be	an	initiating	factor	for	back	pain	(Nguyen,	Poiraudeau,	
&	Rannou,	2015).	The	pathogenesis	of	IVD	degeneration	is	a	com-
plex,	 multifactorial	 process	 with	 large	 contribution	 from	 both	
genetic	 and	 environmental	 components	 (Annunen	 et	 al.,	 1999;	
Pye,	Reid,	Adams,	Silman,	&	O'Neill,	2007;	Song	et	al.,	2013;	Stokes	
&	Iatridis,	2004;	Williams	et	al.,	2013;	Williams	et	al.,	2011).	The	IVD	
is	the	largest	avascular	tissue	in	the	body	and	has	poor	self-healing	
potential	 (Huang,	 Urban,	 &	 Luk,	 2014).	 Under	 pathological	 condi-
tions,	the	IVDs	express	pro-angiogenic	factors	leading	to	neovascu-
larization	(Cornejo,	Cho,	Giannarelli,	Iatridis,	&	Purmessur,	2015;	de	
Vries,	van	Doeselaar,	Meij,	Tryfonidou,	&	Ito,	2018;	Freemont	et	al.,	
1997;	Purmessur,	Freemont,	&	Hoyland,	2008).	However,	the	impact	
of	anti-angiogenic	factors	in	the	maintenance	of	IVD	avascularity	re-
mains unknown.
Tenomodulin	(Tnmd),	a	tendon/ligament-specific	marker	and	an-
ti-angiogenic	molecule,	 is	a	member	of	a	novel	class	protein	family	
of type II transmembrane glycoproteins containing only one other 
homologous	protein,	namely	chondromodulin	I	(Chm1)	that	is	abun-
dant	 in	 cartilage	 tissue	 (Brandau,	Meindl,	 Fässler,	&	Aszódi,	 2001;	
Dex,	Lin,	Shukunami,	&	Docheva,	2016;	Docheva,	Hunziker,	Fässler,	
&	Brandau,	2005;	Kimura	et	al.,	2008;	Shukunami,	Oshima,	&	Hiraki,	
2001).	 The	 cleavage	 of	 the	 highly	 conserved	 C-terminal	 cyste-
ine-rich	domain	of	Tnmd	and	subsequent	secretion	are	required	for	
the	 anti-angiogenic	 activities	 of	 the	 protein	 (Oshima	 et	 al.,	 2004).	
Tnmd	transcript	is	predominantly	expressed	in	hypovascular	tissues,	
such	 as	 tendons,	 ligaments,	 as	well	 as	 eyes	 (Brandau	 et	 al.,	 2001;	
Shukunami	 et	 al.,	 2001).	 Interestingly,	Minogue,	 Richardson,	 Zeef,	
Freemont,	and	Hoyland	(2010)	have	demonstrated	that	Tnmd	mRNA	
has	abundant	expression	in	the	annulus	fibrous	(AF)	and	the	nucleus	
pulposus	(NP).	Concomitantly,	Nakamichi	et	al.	(2016)	showed	that	
Mohawk (Mkx),	an	upstream	gene	of	Tnmd	(Ito	et	al.,	2010),	promotes	
the maintenance and regeneration of the outer annulus fibrous 
(OAF)	of	IVD	suggesting	that	Tnmd may be involved in IVD homeo-
stasis.	To	date,	however,	this	hypothesis	has	not	been	investigated	
in detail.
In	our	previous	studies,	we	compared	Tnmd knockout (Tnmd−/−)	
mice	with	their	wild-type	(WT)	littermates	and	showed	that	the	ab-
sence of Tnmd causes reduced tendon cell proliferation and density 
in	 vivo	 (Docheva	 et	 al.,	 2005),	 coupled	 with	 significantly	 lower	
self-renewal	 and	 augmented	 senescence	 of	 tendon-derived	 stem/
progenitor	cells	(TSPCs)	in	vitro	(Alberton	et	al.,	2015).	Furthermore,	
we observed the pathological thickening and stiffening of collagen I 
(Col	I)	fibers	in	Tnmd−/−	Achilles	tendons	resulting	in	running	distance	
and time failure in Tnmd−/− mice challenged by running tests (Dex 
et	al.,	2017).	Interestingly,	the	local	absence	of	Tnmd in the cardiac 
chordae	tendineae	cordis	(CTC)	promoted	angiogenesis	and	matrix	
metalloproteinases	 (MMPs)	activation	(Kimura	et	al.,	2008),	a	phe-
nomenon also observed when Tnmd−/− mice were subjected to sur-
gically	induced	Achilles	tendon	rupture.	In	this	model,	we	detected	
that genetic ablation of Tnmd leads to blood vessel accumulation ac-
companied	by	abnormal	extracellular	matrix	(ECM)	composition	and	
macrophage profile during the early repair phase of injured tendons 
(Lin	et	al.,	2017).
Cumulatively,	 the	 aforementioned	 data	 reveal	 that	Tnmd plays 
an important regulatory role in the avascular tendogenic/ligamen-
togenic	tissue	homeostasis.	Therefore,	we	hypothesized	that	Tnmd	
in the IVD may act to inhibit vascular ingrowth into this normally 
avascular	 tissue	 and	maintain	 homeostasis.	 Here,	 we	 investigated	
the exact functional role of Tnmd in IVD in vivo and in vitro by phe-
notypization	 of	Tnmd-deficient	 IVD	 tissues	 and	 IVD-derived	 cells.	
Lastly,	to	rule	out	possible	compensatory	effects	between	the	two	
homologs,	 we	 investigated	 the	 IVDs	 of	 Tnmd and Chm1 double 
knockout (Tnmd−/−Chm1−/−)	mice.
2  | RESULTS
2.1 | Tnmd is expressed in the IVD OAF and NP
Tnmd	expression	was	observed	by	us,	along	with	other	researchers,	
in	tendons,	ligaments,	eyes,	and	CTC	(Brandau	et	al.,	2001;	Kimura	
et	al.,	2008;	Shukunami	et	al.,	2001).	 In	the	vertebral	column,	pre-
vious	studies	have	 localized	Tnmd gene expression to areas of the 
IVD	(Minogue	et	al.,	2010;	Nakamichi	et	al.,	2016),	as	well	as	Tnmd	
immunostainings carried out in neonate mice detected robust pro-
tein	expression	in	the	OAF	(Yoshimoto	et	al.,	2017).	To	further	de-
termine the precise distribution of Tnmd in the postnatal and adult 
IVD,	we	first	performed	immunolocalization	studies	on	IVD	tissues	
from	WT	mice	 at	 distinct	 stages	 of	 skeletal	 development	 ranging	
F I G U R E  1  Tnmd	is	mainly	expressed	in	OAF,	and	its	loss	leads	to	age-related	IVD	degeneration.	(a	and	b)	Immunofluorescence	of	Tnmd	
protein	expression	in	developing	adult	and	aged	IVDs	of	WT	mice	shows	that	Tnmd	is	mainly	expressed	in	OAF	and	to	a	lower	extent	in	the	
NP,	and	as	expected,	Tnmd	was	not	detected	in	Tnmd−/−	IVDs.	Fluorescence	intensity	analysis	revealed	an	expression	peak	at	1	month	and	
expression downregulation from 6 months onwards (n	=	3–5	animals).	(c)	Western	blot	confirmed	that	Tnmd	protein	expression	is	higher	at	
1 month than at 6 months (n	=	3	animals).	(d	and	e)	IHC	of	the	human	IVDs	confirmed	that	TNMD	protein	is	mainly	found	in	the	OAF	and	to	
a	lesser	extended	in	the	NP	(two-tailed	nonparametric	Mann–Whitney	test;	n	=	5	samples).	(f)	Representative	H&E	stainings	of	human	IVD	
(n	=	5	samples).	(g)	H&E	staining	demonstrates	greater	degenerative	changes	in	Tnmd−/−	IVDs	when	compared	to	WT	at	6	and	18	months.	
(h)	Safranin	O	staining	reveals	small	roundish	chondrocyte-like	cells	in	IAF	and	NP	of	Tnmd−/−	IVDs.	(i	and	j)	Histological	grading	and	disc	
height index calculation show in Tnmd−/−	mice	significantly	widespread	degeneration	compared	to	WT	at	both	examined	stages	(two-tailed	
nonparametric	Mann–Whitney	test;	6-month-old	mice,	n	=	5	animals;	18-month-old	mice,	n	=	3	animals).	**p < .01; ***p	<	.001.	d,	day;	H&E,	
hematoxylin–eosin;	IAF,	inner	annulus	fibrous;	IHC,	immunohistochemistry;	IVD,	intervertebral	disc;	mo,	month;	NB,	newborn;	NP,	nucleus	
pulposus;	OAF,	outer	annulus	fibrous;	WT,	wild-type.	Scale	bar,	200	μm
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from	newborn	to	18	months	of	age.	We	observed	that	Tnmd	is	pre-
dominantly	produced	and	deposited	in	the	ECM	of	the	OAF,	as	well	
as	 to	 a	 lesser	 extent	 in	 the	NP	 regions.	 Scarce	 positive	 signals	 in	
the	 inner	annulus	 fibrous	 (IAF)	and	the	cartilaginous	endplate	 (EP)	
were	also	detected;	however,	those	were	primarily	cellular	and	not	
in	the	ECM	(Figure	1a).	Notably,	Tnmd	signals	in	the	OAF	and	the	NP	
gradually	peaked	at	1	month	of	age,	while	 it	dropped	at	6	months	
of	age	corresponding	to	the	early	 IVD	degeneration	stage	 in	mice,	
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and	then	further	decreased	at	12	and	18	months	(Figure	1b).	As	ex-
pected,	Tnmd	was	not	detected	in	Tnmd−/−	IVDs	(Figure	1a).	Western	
blotting of IVD tissue protein extracts confirmed that the protein 
levels	of	Tnmd	are	higher	at	1	month,	when	compared	to	6	months	
(Figure	1c)	as	well	as	that	in	the	IVD;	similar	to	Achilles	tendon	and	
CTC,	Tnmd	is	fully	processed	to	its	16	kDa	C-terminal	portion.	We	
also	assessed	the	expression	of	TNMD	in	human	lumbar	discs	(Table	
S1).	Consistent	with	the	observation	in	mice,	TNMD	protein	was	pre-
dominantly	found	in	the	ECM	of	the	OAF	and	to	a	lesser	extent	in	the	
NP	regions	(Figure	1d–f).
2.2 | The absence of Tnmd leads to age-related IVD 
degeneration
To	analyze	the	potential	 involvement	of	Tnmd	during	naturally	oc-
curring	 IVD	 degeneration	 in	 mouse,	 6-	 and	 18-month-old	 lumbar	
IVDs	were	 first	 examined	 by	 hematoxylin–eosin	 (H&E)	 and	 safra-
nin	O	staining	 for	pathological	changes.	 Importantly,	Tnmd−/− mice 
showed	 higher	 levels	 of	 degenerative	 changes	 compared	 to	 WT	
mice.	 Lamellae	 appeared	 thinner,	 looser,	 and	 fibrillated	 in	Tnmd−/− 
AF	 (Figure	 1g).	 In	 the	 IAF	 and	 NP	 areas	 of	 Tnmd−/−	 IVDs,	 small	
round	cells,	morphologically	resembling	chondrocytes,	were	visible.	
Cumulatively,	such	abnormalities	are	often	described	as	degenera-
tive	changes	(Nakamichi	et	al.,	2016),	and	they	were	even	more	evi-
dent in the Tnmd−/−	discs	at	18	months	(Figure	1h).	By	implementing	
the	histological	scoring	system	for	mouse	IVD	(Tam	et	al.,	2018),	we	
detected	higher	degenerative	scores	at	6	and	18	months	in	Tnmd−/− 
mice,	 reflective	 of	 a	 significantly	 widespread	 IVD	 degeneration	
compared	 to	WT	 (Figure	1i).	 In	addition,	 calculation	of	disc	height	
index	(Masuda	et	al.,	2005)	showed	lower	values	for	Tnmd−/− IVDs at 
both	examined	stages	(Figure	1j).	Thus,	our	results	demonstrate	that	
Tnmd is associated with IVD homeostasis and its loss leads to pro-
found tissue degeneration that advances during the aging process.
2.3 | Tnmd deficiency results in 
abnormal diameters and biomechanical 
properties of IVD collagen fibrils, accompanied by 
reduced expression of multiple IVD- and tendon/
ligament-related genes in the OAF
Since	Tnmd	is	highly	expressed	in	the	OAF	and	a	disorganized	OAF	
morphology	characterized	by	thinner	collagen	fibers	 (Figure	S1a,b)	
was observed in Tnmd−/−	 mice,	 we	 next	 examined	 the	 nanotopo-
graphical	and	biomechanical	properties	of	6-month-old	Tnmd−/− and 
WT	 IVDs.	 We	 applied	 indentation-type	 atomic	 force	 microscopy	
(IT-AFM)	to	quantitatively	assess	collagen	fibril	diameters	and	com-
pressive	stiffness	of	AF.	Height	images	revealed	that	the	collagen	fi-
brils of Tnmd−/−	OAF	were	more	frayed	and	interrupted	by	gaps,	and	
vertical deflection images indicated that the collagenous network of 
Tnmd−/−	OAF	was	less	dense	compared	to	WT	(Figure	2a).	The	fibril	
diameters	in	OAF	and	IAF	were	significantly	smaller	in	Tnmd−/− than 
in	WT	mice	 (Figure	 2b).	 Indentation	measurements	 on	 native	 IVD	
tissues indicated a bimodal stiffness distribution in both genotypes 
(Figure	2c).	In	Tnmd−/−	OAF	and	IAF,	the	proteoglycan	stiffness	peaks	
were	detected	at	1.240	±	0.098	and	0.272	±	0.004	MPa	and	those	
of	collagen	network	at	2.972	±	0.033	and	0.532	±	0.049	MPa,	 re-
spectively.	In	WT	OAF	and	IAF,	the	average	proteoglycan	stiffness	
peaks	were	8.134	±	0.307	and	0.285	±	0.013	MPa,	while	the	colla-
gen	stiffness	peaks	were	14.019	±	0.493	and	0.581	±	0.0063	MPa,	
respectively.	 In	sum,	the	overall	compressive	stiffness	of	OAF	was	
markedly lower in Tnmd−/−	than	WT	mice,	but	the	IAF	biomechanical	
properties were not significantly different between genotypes.
Changes	in	expression	levels	of	ECM	and	cross-linking	molecules	
can	 lead	 to	 loss	of	mechanical	properties	and,	 thus,	 impaired	abil-
ity	of	the	OAF	to	resist	compression	delivered	to	the	IVD	and	par-
ticularly	 the	NP	 (Feng,	Danfelter,	 Strömqvist,	&	Heinegård,	2006).	
Therefore,	we	 analyzed	 how	 the	 ablation	 of	Tnmd affects the ex-
pression	 levels	 of	 IVD-	 and	 tendon/ligament-related	 genes	 using	
quantitative	 real-time	 PCR	 (qRT–PCR)	 on	Tnmd−/−	 and	WT	 lumbar	
OAF	tissue-derived	mRNA.	We	observed	downregulation	of	multi-
ple	IVD-	and	tendon/ligament-related	genes	including	scleraxis	(Scx),	
Mkx,	collagens	I,	V,	XII,	XIV,	and	XV	(Col1a1,	Col5a1,	Col12a1,	Col14a1,	
Col15a1),	early	growth	response	protein	1	and	2	(Egr1,	Egr2),	tenascin	
C (Tnc),	thrombospondin	2	and	4	(Thbs2,	Thbs4),	transforming	growth	
factor beta 1 (Tgfb1),	 alpha	 smooth	 muscle	 actin	 (Acta2),	 ephrin	
type-A	receptor	4	(Epha4),	asporin	(Aspn),	and	fibromodulin	(Fmod),	
without affecting those of collagens III and VI (Col3a1,	Col6a1),	eyes	
absent homolog 1 and 2 (Eya1,	Eya2),	sine	oculis	homeobox	homo-
log 1 and 2 (Six1,	Six2),	cartilage	oligomeric	protein	(Comp),	lubricin	
(Prg4),	 biglycan	 (Bgn),	 decorin	 (Dcn),	 fibronectin	 (Fn),	 lysyl	 oxidase	
(Lox),	lumican	(Lum),	procollagen-lysine,	2-oxoglutarate-5-dioxygen-
ase 1 (Plod1),	and	transglutaminase	2	(Tgm2)	in	Tnmd−/− compared to 
WT	mice	(Figure	2d).	Additionally,	we	compared	the	mRNA	levels	of	
IVD-	and	tendon/ligament-related	genes	between	tendon	and	OAF	
tissues	from	both	genotypes,	and	showed	that	the	absence	of	Tnmd 
in	 the	 tendon	and	 the	OAF	causes	opposite	effects	on	 the	mRNA	
expression levels of Scx,	Mkx,	Col14a1,	Col15a1, and Prg4	(Figure	S1c)	
suggesting	tissue-specific	regulation.
Taken	together,	these	findings	demonstrate	that	Tnmd is a critical 
factor	required	to	maintain	the	structural	and	biomechanical	proper-
ties	of	the	OAF	collagen	fibrils	likely	through	the	modulation	of	ECM	
gene expression.
2.4 | Increased angiogenesis, macrophages 
infiltration, and apoptosis in Tnmd−/− OAF
The	AF	and	EP	are	natural	barriers	resistant	to	vascular	invasion	due	
to intrinsic angiogenic inhibitors. IVD degeneration is often marked 
by	blood	vessel	ingrowth,	infiltration	of	inflammatory	cells,	and	in-
creased	cell	apoptosis	(de	Vries,	van	Doeselaar,	Meij,	Tryfonidou,	&	
Ito,	2018;	Freemont	et	al.,	1997;	McCann	&	Séguin,	2016;	Phillips,	
Jordan-Mahy,	Nicklin,	&	Le	Maitre,	2013).	For	this	reason,	we	then	
focused	our	investigation	on	the	OAF	zone	in	6-month-old	mice	in	
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order to reveal if Tnmd contributes to the maintenance of avascu-
larity.	We	 found	 that	 the	occurrence	of	CD31-labeled	vessels	was	
increased	in	the	OAF	of	Tnmd−/−	mice	when	compared	with	WT	mice	
(Figure	3a,b).	Infiltration	of	macrophages	was	confirmed	by	staining	
with	F4/80	monoclonal	antibody	directed	specifically	against	mouse	
macrophages,	 demonstrating	 a	 significant	 increase	 in	macrophage	
number	 in	 the	 OAF	 zone	 of	 Tnmd−/−	 IVDs	 (Figure	 3c,d).	 We	 also	
performed	 in	 situ	 terminal	 deoxynucleotidyl	 transferase-mediated	
dUTP-biotin	 nick	 end	 labeling	 (TUNEL)	 assay	 and	 immunofluores-
cent	staining	for	p53,	to	detect	if	apoptotic	and	senescent	cells	are	
present	 in	 the	OAF	 of	Tnmd−/−	mice,	 landmarks	 of	 IVD	 degenera-
tive	processes	(Feng	et	al.,	2016).	We	observed	a	higher	number	of	
TUNEL-	 and	 p53-positive	 cells	 in	 Tnmd−/−	 compared	 to	 WT	 OAF	
(Figure	 3e,f,	 Figure	 S1d,e).	 Lastly,	 we	 carried	 out	 immunofluores-
cent	 staining	 for	 the	proliferative	marker,	PCNA,	which	confirmed	
a	 lower	 number	 of	 dividing	 cells	 in	 the	OAF	 zone	 of	 6-month-old	
Tnmd−/−	than	WT	IVDs	(Figure	3g,h).	Taken	together,	the	above	find-
ings indicate the essential role of the locally expressed Tnmd in IVD 
homeostasis,	 its	 loss	 led	 to	 induced	 angiogenesis,	macrophage	 in-
filtration,	 and	 apoptosis,	 while	 cell	 proliferation	 was	 significantly	
reduced.
2.5 | Manifestation of hypertrophic 
chondrocytes and Col X-rich matrix in the NP of 
Tnmd−/− mice
It has been shown that ectopic calcifications in IVDs are a known 
characteristic	 of	 IVD	 degeneration	 (Hristova	 et	 al.,	 2011;	 Illien-
Jünger	 et	 al.,	 2016).	 The	 observed	 small	 round	 cells,	 resembling	
chondrocyte	morphology,	 in	the	Tnmd−/−	NP	prompted	us	to	test	
whether the loss of Tnmd is accelerating hypertrophic chondro-
cyte-like	 occurrence.	 The	 major	 proteoglycan	 of	 the	 NP	 is	 ag-
grecan	(Acan),	which	due	to	its	highly	anionic	glycosaminoglycan	
content	provides	osmotic	properties,	enabling	the	NP	to	maintain	
height	and	turgor	against	compressive	loads	(Bedore	et	al.,	2013).	
F I G U R E  2   Tnmd	deficiency	causes	altered	ECM	nanostructure	and	mechanical	properties	of	the	OAF	in	6-month-old	mice.	(a)	AFM	
height	images	(upper	panels	for	both	genotypes)	show	that	the	collagen	fibrils	in	Tnmd−/−	OAF	were	more	frayed	and	interrupted	by	gaps,	
and	vertical	deflection	images	(lower	panels)	demonstrate	that	the	collagen	network	in	this	region	was	less	dense	in	Tnmd−/− compared to 
WT.	(b)	Comparison	of	the	collagen	fibril	diameters	reveals	significantly	smaller	average	size	in	Tnmd−/−	than	in	WT	AF	(two-tailed	unpaired	
Student's	t test; n	=	3	animals,	and	200	fibrils	were	analyzed	per	genotype).	(c)	Plots	of	compressive	stiffness	data	obtained	by	indentation	
AFM	demonstrated	that	ECM	compressive	stiffness	was	markedly	lower	in	the	OAF	regions	of	Tnmd−/− IVDs but not noticeably different in 
the	IAF	regions	(two-tailed	unpaired	Student's	t test; n	=	3	animals).	(d)	Significant	downregulation	of	numerous	IVD-	and	tendon/ligament-
related genes was detected in Tnmd−/−	OAF	by	qRT–PCR	analysis.	For	calculation	of	fold	changes,	WT	was	set	to	1	(two-tailed	unpaired	
Student's	t test; n	=	3	animals).	*p < .05; **p < .01; ***p	<	.001.	AF,	annulus	fibrous;	Col,	collagen;	ECM,	extracellular	matrix;	IAF,	inner	annulus	
fibrous;	IVD,	intervertebral	disc;	OAF,	outer	annulus	fibrous;	PG,	proteoglycan;	qRT–PCR,	quantitative	real-time	PCR;	WT,	wild-type.	Scale	
bar,	1	μm
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Therefore,	we	explored	Acan	expression	by	immunohistochemis-
try	 (IHC)	 in	 IVD	sections	 from	both	genotypes.	At	6	months,	no	
noticeable	 change	 in	Acan	 localization	was	 found	 in	Tnmd−/−	NP	
compared	to	WT	NP.	However,	the	deposition	of	Acan	was	signifi-
cantly	decreased	in	Tnmd-deficient	NP	at	18	months	(Figure	4a,b).	
More	specifically,	it	has	been	proposed	that	Acan	production	ratio	
within	 the	NP	to	hyaline	cartilage	 is	approximately	27:2	 (Mwale,	
Roughley,	 &	 Antoniou,	 2004).	 Hence,	 Acan	 downregulation	 can	
lead	to	appearance	of	hypertrophic-like	chondrocytes,	which	sub-
sequently	contribute	to	calcification,	due	to	the	available	free	cal-
cium	 ions	 (Hristova	 et	 al.,	 2011).	 In	 order	 to	 track	 hypertrophic	
chondrocyte-like	differentiation	in	the	NP,	we	next	 implemented	
immunofluorescence	analysis	for	Sox9,	the	key	pro-chondrogenic	
transcription	 factor	 (Takimoto,	Oro,	Hiraki,	&	Shukunami,	2012),	
and	Runx2	and	Col	X,	markers	of	hypertrophic	chondrocytes	(van	
der	Kraan	&	van	den	Berg,	 2012).	Tnmd−/−	NP	 showed	 composi-
tional	 alterations	 associated	 with	 increased	 levels	 of	 Sox9-	 and	
Runx2-positive	cells	and	Col	X	deposition	at	18	months	of	age	in	
contrast	 to	WT	mice	 (Figure	 4c–h).	 These	 protein	 data	 together	
with the observed transcriptional changes of multiple genes 
(Figure	2d)	 suggested	 that	Tnmd deficiency alters the balance in 
the expression of ECM molecules and is manifested by accumula-
tion	of	hypertrophic	chondrocytes	and	Col	X-rich	matrix	in	the	NP,	
indicating clearly substantial IVD cell dysfunction.
2.6 | Tnmd and Chm1 double mutant mice 
display not only accelerated IVD degeneration but 
also ectopic bone formation
Our findings suggest that Tnmd contributes to protect the IVD 
from	vascularization	and	inflammation.	However,	our	present	data	
do	not	exclude	the	possibility	of	the	existence	of	other	anti-angio-
genic	factors.	Chm1,	the	only	Tnmd	homologous	protein	(Brandau	
et	al.,	2001;	Shukunami	et	al.,	2001),	is	a	cartilage-specific	angio-
genesis	inhibitor	(Hiraki	et	al.,	1997;	Yoshioka	et	al.,	2006)	that	has	
been previously shown to be also highly expressed in the IVD dur-
ing the gestational period and gradually downregulated after matu-
ration	(Takao,	Iwaki,	Kondo,	&	Hiraki,	2000).	Immunofluorescence	
staining for Chm1 in IVD showed that it is deposited in the ECM 
of	NP,	as	well	as	expressed	in	cells	from	EP	and	OAF	(Figure	5a).	
Western	 blotting	 and	 densitometric	 analyses	 of	 Chm1-positive	
areas revealed that Chm1 levels are decreased in Tnmd−/− IVD 
when	compared	with	WTs	 (Figure	5b,c).	These	 lines	of	evidence	
suggest that the expression of Tnmd and Chm1 may be coordinated 
between	the	cell	populations	of	NP,	AF,	and	EP.	Therefore,	we	car-
ried out a pilot investigation of Tnmd−/−Chm1−/− mouse model to 
elucidate for the first time the relationship between both proteins 
and	 IVD	 degeneration.	 Interestingly,	 H&E	 and	 safranin	 O	 stain-
ing demonstrated that Tnmd−/−Chm1−/− mice display more severe 
F I G U R E  3  Loss	of	Tnmd	results	in	blood	vessel	ingrowth,	macrophage	infiltration,	and	increased	cell	apoptosis	in	the	OAF.	(a	and	b)	
Immunofluorescence	staining	with	anti-CD31	antibody	reveals	increased	vessel	number	in	the	OAF	of	Tnmd−/−	than	WT.	(c	and	d)	Higher	
number	of	F4/80-positive	macrophages	was	detected	in	the	OAF	of	Tnmd−/− versus	WT.	(e	and	f)	TUNEL	staining	demonstrates	increased	
number of apoptotic cells in Tnmd−/−	OAF	than	WT.	(g	and	h)	Reduced	number	of	proliferating	cells	was	observed	in	Tnmd−/−	compared	to	WT	
mice	by	PCNA	immunofluorescence	staining.	All	quantitative	histomorphometry	data	were	assessed	by	two-tailed	nonparametric	Mann–
Whitney	test;	n = 5 animals. *p	<	.05.	EP,	endplate;	IAF,	inner	annulus	fibrous;	OAF,	outer	annulus	fibrous;	TUNEL,	transferase-mediated	
dUTP-biotin	nick	end	labeling;	WT,	wild-type;	white	dotted	line,	OAF-IAF	boundary.	Scale	bar,	200	μm
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IVD degeneration associated with ectopic bone formation in the 
IVDs	 at	 18	months	 when	 compared	 with	 Tnmd−/−	 and	WT	mice	
(Figure	5d–f).	Immunofluorescence	of	CD31	showed	that	the	OAF	
of Tnmd−/−Chm1−/−	mice	 contained	many	 capillary-like	 structures	
(Figure	 5g).	 Furthermore,	 multiple	 F4/80-labeled	 macrophages	
were	distributed	in	the	AF	and	NP	regions	(Figure	5h)	and,	lastly,	
ectopic	 ossification	 sites	were	 detected	with	 osteopontin	 (Opn,	
bone-specific	marker)	antibody	in	Tnmd−/−Chm1−/−	IVDs	Figure	5i).	
Based	on	our	novel	data,	we	concluded	that	simultaneous	loss	of	
Tnmd and Chm1 causes a more progressive IVD degenerative phe-
notype than Tnmd single knockout. It remains to be investigated 
to what extent these mutant variants compare to Chm1 single 
knockout.
2.7 | Loss of Tnmd in OAF cells suppresses their 
proliferation and promotes cell apoptosis
To further understand the mechanisms underlying the roles of Tnmd 
in	 IVD	homeostasis,	we	performed	 in	vitro	studies	with	OAF	cells	
isolated	 from	 12-month-old	 Tnmd−/−	 or	 WT	 lumbar	 IVDs	 (Figure	
S2a).	 First,	 we	 characterized	 the	 obtained	 cell	 populations	 by	 im-
munofluorescence	 staining	 and	 RT–PCR.	 Fmod,	 an	 accepted	 AF-
specific	marker	in	rodent	(Leung,	Tam,	Chan,	Chan,	&	Cheung,	2011;	
Smits	&	Lefebvre,	2003),	was	expressed	in	both	genotypes,	but	its	
immunostaining signal was weaker in Tnmd−/−	OAF	cells	compared	
with	WTs	(Figure	S2b,g).
WT	OAF	cells	were	strongly	expressing	Tnmd,	while	as	expected	
Tnmd was not produced by Tnmd−/−	 cells	 (Figure	 S2c).	 To	 analyze	
whether	the	synthesis	of	ECM	proteins	by	the	OAF	cells	 is	altered	
due to Tnmd	 deficiency,	 we	 next	 performed	 immunofluorescence	
analysis	for	Col	I,	which	is	the	main	protein	component	of	OAF;	Fn,	
which	plays	a	pivotal	role	in	facilitating	AF	cell	attachment	and	fiber	
alignment	 (Attia,	Santerre,	&	Kandel,	2011);	and	Lum,	which	 inter-
acts	with	collagen	fibrils	and	contributes	to	AF	mechanical	proper-
ties	(Sztrolovics,	Alini,	Mort,	&	Roughley,	1999).	In	vitro, only a slight 
decrease in the expression of the three proteins was observed in 
Tnmd−/−	OAF	cells	(Figure	S2d–g).	Semiquantitative	RT–PCR	revealed	
that Tnmd	mRNA	could	not	be	detected,	while	Chm1	mRNA	levels	
were reduced in Tnmd−/−	OAF	cells	(Figure	S2h).
To further evaluate the role of Tnmd	 in	OAF	 cell	 behavior,	we	
carried	 out	 time-lapse	 imaging	 of	 random	 migration,	 followed	 by	
plotting	of	forward	migration	index	(FMI).	Our	results	showed	that	
Tnmd−/−	OAF	cells	were	less	migratory	than	WT	cells	(Figure	S3a,b).	
Quantification	 of	 velocity,	 accumulated	 and	 Euclidean	 distance	
clearly	 indicated	 that	 the	 observed	 effect	 was	 significant	 (Figure	
S3c,d).	 Furthermore,	 during	 0,	 3,	 5,	 and	 7	 days	 of	 culture,	 DNA-
based	 CyQUANT	 assays	 showed	 that	 the	 proliferation	 of	 Tnmd−/− 
OAF	cells	was	 significantly	 reduced	compared	 to	 that	of	WT	cells	
(Figure	S3e).	Lastly,	TUNEL	assays	demonstrated	that	Tnmd−/−	OAF	
F I G U R E  4  Accumulation	of	hypertrophic	chondrocyte-like	alterations	in	the	NP	of	Tnmd−/−	mice.	(a	and	b)	Significant	downregulation	
of	Acan	protein	expression	was	detected	at	18	months	by	immunofluorescent	imaging	and	fluorescence	intensity	analysis	in	Tnmd−/−	NP	
compared	to	WT.	(c–h)	Immunofluorescence	stainings	with	anti-Sox9,	anti-Runx2	and	anti-Col	X	antibodies	reveal	increased	expression	
levels of the three hypertrophy markers in Tnmd−/−	NPs	compared	with	WT	at	18	months.	All	quantitative	histomorphometry	data	were	
assessed	by	two-tailed	nonparametric	Mann–Whitney	test;	6-month-old	mice,	n	=	5	animals;	18-month-old	mice,	n = 3 animals. *p < .05; 
**p	<	.01.	AF,	annulus	fibrous;	EP,	endplate;	mo,	month;	NP,	nucleus	pulposus;	WT,	wild-type.	Scale	bar,	200	μm
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cell population contained increased number of apoptotic cells com-
pared	to	WT	cell	population	(Figure	S3f,g).	Taken	together,	we	val-
idated	the	OAF	phenotype	of	our	isolated	cells	and	concluded	that	
the loss of Tnmd causes reduction in their proliferative and migratory 
potential but an increase in apoptotic risk.
2.8 | Human umbilical vein endothelial cells migrate 
more toward Tnmd−/− OAF cells which exhibit 
elevation in p65 and MMPs expression levels
Following	 our	 observation	 of	 increased	 angiogenesis	 and	 mac-
rophage infiltration in Tnmd−/−	OAF,	we	investigated	the	human	um-
bilical	vein	endothelial	cells	(HUVECs)	migratory	capacity	toward	WT	
or Tnmd−/−	OAF	 cells	 by	 implementing	 transwell	 assays	 and	 found	
that	 loss	 of	 Tnmd	 in	 OAF	 supernatant	 promoted	 their	 migratory	
capacity	compared	to	co-culture	with	WT	OAF	cells	 (Figure	6a–c).	
Immunofluorescence analysis revealed that the number of nuclei 
positive	 for	p65,	a	key	 regulator	of	nuclear	 factor-kappa-B	activa-
tion	and	function,	was	significantly	 increased	in	Tnmd−/− compared 
with	WT	OAF	cells	(Figure	6d,e),	which	was	in	parallel	with	elevated	
expression	of	MMP-3	and	MMP-9	 in	Tnmd−/−	OAF	cells	 compared	
with	 WT	 OAF	 cells	 (Figure	 6f–i).	 Thus,	 our	 results	 suggest	 that	
Tnmd-deficient	OAF	cells	exhibit	elevated	p65,	MMP-3,	and	MMP-9	
expression and that the absence of secreted Tnmd by these cells sig-
nificantly	promotes	HUVECs	migration.
3  | DISCUSSION
Low	back	pain	is	an	enormous	medical	and	socioeconomic	burden	in	
modern	society.	Although	there	are	many	etiologies	for	the	devel-
opment	of	low	back	pain,	a	main	component	appears	to	be	IVD	de-
generation,	including	neovascularization	and	inflammatory	element	
F I G U R E  5   Double knockout for Tnmd and Chm1	lead	to	accelerated	IVD	degeneration	coupled	with	ectopic	bone	formation.	(a	and	b)	
Immunofluorescence	analysis	of	Chm1	expression	shows	Chm1	major	localization	in	the	NP	as	well	as	lower	protein	levels	in	Tnmd−/− than 
WT	IVD	at	6	months	(two-tailed	nonparametric	Mann–Whitney	test;	n	=	5	animals).	(c)	Western	blotting	confirmed	the	downregulation	
of Chm1 protein in Tnmd−/−	compared	to	WT	IVD	(n	=	3	animals).	(d-f)	H&E	and	safranin	O	staining	reveal	advanced	IVD	degeneration	
and ectopic bone formation in Tnmd−/−Chm1−/−	mice,	and	histological	grading	shows	significantly	worsened	scores	at	18	months	in	
Tnmd−/−Chm1−/− mice compared to Tnmd−/−	and	WT	mice	(one-way	ANOVA	was	followed	by	Bonferroni	post	hoc	correction,	n	=	3	animals).	
(g)	Immunofluorescence	analysis	for	CD31	demonstrate	that	Tnmd−/−Chm1−/−	OAF	contain	many	capillary-like	structures	(n	=	3	animals).	(h)	
Immunofluorescence	analysis	for	F4/80	shows	many	macrophages	were	distributed	in	and	around	the	NP	of	Tnmd−/−Chm1−/− mice (n = 3 
animals).	(i)	Multiple	sites	of	ectopic	ossifications	in	Tnmd−/−Chm1−/− IVD were observed by carrying out Opn immunostaining (n	=	3	animals).	
*p < .05; **p < .01; ***p	<	.001.	AF,	annulus	fibrous;	EP,	endplate;	H&E,	hematoxylin–eosin;	IAF,	inner	annulus	fibrous;	IVD,	intervertebral	disc;	
NP,	nucleus	pulposus;	OAF,	outer	annulus	fibrous;	WT,	wild-type;	black	arrows,	chondrocyte-like	cells;	white	arrows,	ectopic	ossifications;	
white	dotted	line,	OAF-IAF	boundary.	Scale	bar:	200	μm
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(Cornejo,	Cho,	Giannarelli,	Iatridis,	&	Purmessur,	2015;	Freemont	et	
al.,	1997;	Kwon,	Moon,	Kwon,	Park,	&	Kim,	2017;	Risbud	&	Shapiro,	
2014).	 In	the	present	study,	we	demonstrate	the	important	role	of	
Tnmd in prevention of IVD degeneration by maintaining the avascu-
lar	nature	of	the	IVD	(Figure	6j).
Based	on	our	 initial	 investigation	at	the	protein	 level,	we	could	
show	that	Tnmd	is	strongly	expressed	in	the	ECM	of	the	OAF,	while	
Chm1	is	predominantly	found	in	the	NP.	We	could	detect	to	a	lower	
extent	 a	 signal	 for	 Tnmd	 also	 in	 the	NP;	 however,	 this	 should	 be	
taken	with	caution	considering	the	highly	conserved	C-terminus	be-
tween both proteins against which the primary antibody was raised. 
Moreover,	we	could	 show,	 similar	 to	 the	Achilles	 tendon	and	CTC	
(Dex	 et	 al.,	 2016),	 that	 Tnmd	 processing	 in	 the	 IVD	 undergoes	 a	
proteolytic	cleavage	at	 its	16kDa	C-terminal	portion.	Thus,	we	 re-
port for the first time the expression pattern of Tnmd protein in the 
ECM	of	the	IVD,	but	also	revealing	that	Tnmd	is	downregulated	at	
6 months of age.
Neovascularization	 allows	 the	 infiltration	 of	macrophages	 into	
the	 IVD	 triggering	 inflammation	 (Fontana,	 See,	 &	 Pandit,	 2015;	
Nakazawa	 et	 al.,	 2018;	Walker	 &	 Anderson,	 2004),	 which	 in	 turn	
can	 further	 amplify	 the	 vascularization	 (Cornejo,	 Cho,	 Giannarelli,	
Iatridis,	&	Purmessur,	 2015;	 Lee	 et	 al.,	 2011),	 thereby	 triggering	 a	
self-perpetuating	 process.	 Here,	 we	 revealed	 that	 the	 absence	 of	
Tnmd activates angiogenesis and macrophage infiltration in the IVD 
in	vivo,	as	well	as	HUVECs	migration	in	an	in	vitro	co-culture	setting	
with	 OAF-derived	 cells.	 Furthermore,	 we	 also	 provide	 direct	 evi-
dence that both Tnmd and Chm1	act	as	anti-angiogenic	cues	in	the	
IVD due to the observed severe IVD phenotype in the double mu-
tant	animals.	We	detected	not	only	pronounced	vascularization	and	
infiltration of inflammatory cells into the matrix of the IVD but also 
unusual calcification. These data provide a new insight into the mo-
lecular mechanisms underlying the maintenance of IVD avascularity 
and implicate that disruption of its homeostasis leads to pathological 
status.
The	 ECM	 composition	 and	 organization	 are	 very	 important	
for	 IVD	 structure	 and	 function;	 hence,	 alterations	 in	 the	 ECM	
can	 also	 contribute	 to	 IVD	 degeneration	 (Cs-Szabo	 et	 al.,	 2002;	
Hoogendoorn	 et	 al.,	 2008;	 Liu	 et	 al.,	 2017;	 Zhang	 et	 al.,	 2013).	
F I G U R E  6   Tnmd−/−	OAF	cells	promote	HUVECs	migration	and	have	elevated	p65	and	MMPs	expression.	(a)	Experimental	design	of	
HUVECs-OAF	cells	co-culture	experiments.	(b	and	c)	Significantly	increased	migration	of	HUVECs	toward	Tnmd−/−	OAF	cells.	Representative	
images	of	the	bottom	side	of	the	transwell	membrane	taken	after	36	hr	of	co-culturing	(n	=	3	independent	experiments).	(d–i)	Tnmd−/− 
OAF	cells	exhibit	upregulated	protein	expression	of	p65	(component	NF-κB	complex),	MMP-3,	and	MMP-9	compared	with	WT	cells	
(two-tailed	nonparametric	Mann–Whitney	test;	n	=	3	independent	experiments).	(j)	Cartoon	highlighting	the	hallmarks	of	Tnmd−/− IVD 
phenotype. *p < .05; **p	<	.01.	Scale	bar:	100	μm.	HUVEC,	human	umbilical	vein	endothelial	cells;	IVD,	intervertebral	disc;	MMP,	matrix	
metalloproteinases;	NF-κB,	nuclear	factor-kappa-B;	OAF,	outer	annulus	fibrous;	WT,	wild-type
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In	general,	IVD	degeneration	starts	with	proteoglycan	breakdown	
leading to diminished water retention and disc dehydration. Our 
previous nanostructural and biomechanical analyses of the col-
lagen	matrix	 in	Achilles	 tendons	demonstrated	 that	 the	 absence	
of Tnmd causes thickening and stiffening of the collagen fibrils 
(Docheva	et	al.,	2005).	Therefore,	we	analyzed	whether	 the	 lack	
of Tnmd	 affects	 the	 collagen	 fibrils	of	 the	AF.	 In	 contrast	 to	our	
previous	results,	we	found	out	that	Tnmd−/−	OAF	contain	collagen	
fibrils	with	smaller	calibers	and	lower	compressive	stiffness,	which	
cannot provide enough strength and proper load distribution over 
large	parts	of	the	OAF.	According	to	these	results	and	our	previous	
finding that Tnmd is a mechanosensitive and mechanoregulated 
gene	(Dex	et	al.,	2017),	we	propose	that	the	above-described	phe-
notypic differences between tendon and IVD tissues are the con-
sequence	 of	 the	 different	 biomechanical	 environments,	 namely	
IVDs are subjected mainly to compressive stress while tendons to 
tensile forces.
Altered	OAF	matrix	can	hinder	the	ability	of	the	tissue	to	with-
stand mechanical load and in turn can increase the likelihood of 
tear	formation	(Gruber	&	Hanley,	1998;	Guterl	et	al.,	2013;	Iatridis,	
Nicoll,	 Michalek,	 Walter,	 &	 Gupta,	 2013;	 Roberts	 et	 al.,	 2008;	
Shukunami	et	al.,	2018).	Interestingly,	the	absence	of	Tnmd in ten-
don	versus	OAF	tissues	caused	the	opposite	effect	on	the	mRNA	
expression levels of several ECM genes such as Col14a1,	Col15a1, 
and Prg4, as well as the transcription factors Scx,	a	direct	transac-
tivator	of	Tnmd	(Shukunami	et	al.,	2018),	and	Mkx,	both	known	to	
regulate	collagens.	Furthermore,	we	detected	elevated	expression	
of	MMP-3	and	MMP-9	in	Tnmd−/−	OAF	cells;	thus,	soluble	matrix	
proteins can be extruded from the tissue by mechanical load-
ing	and	enhance	the	degenerative	process	 (Kamper	et	al.,	2016).	
Notably,	the	glycosaminoglycan	to	hydroxyproline	ratio	within	the	
NP	of	young	adults	is	approximately	27:1,	whereas	the	ratio	within	
the hyaline cartilage of the same individuals is about 2:1 (Mwale et 
al.,	2004).	In	our	study,	decreased	Acan	content	in	the	Tnmd−/−	NP,	
paralleled	by	increased	Sox9,	Runx2,	and	Col	X	levels,	is	indicative	
for	a	 transition	 from	a	hydrated	gel-like	NP	 to	a	more	hypertro-
phic	chondrocyte-like	matrix	that	is	involved	in	IVD	degeneration.	
Altogether,	 in	 such	 circumstances,	 sprouting	 of	 blood	 vessels	 in	
the	 abnormal	 OAF	matrix	 and	 further	 toward	 the	 center	 of	 the	
IVD can facilitate ectopic ossification via intermediate hypertro-
phy	state	(Roberts	et	al.,	2008).
Apoptosis	 is	 known	 to	 be	 a	 component	 of	 IVD	degeneration	
(Gruber	&	Hanley,	1998).	Previously,	we	have	reported	a	reduced	
proliferative rate in Tnmd−/−	 tendon	 tissues	 and	 derived	 cells,	
as	 well	 as	 an	 increased	 number	 of	 p53-positive	 cells	 in	 Tnmd−/− 
Achilles	 tendons	 (Alberton	 et	 al.,	 2015;	 Docheva	 et	 al.,	 2005).	
Therefore,	 another	 important	 point	 that	 we	 examined	 was	 the	
effect of Tnmd on cell proliferation and apoptosis in the IVD. 
Interestingly	and	similar	to	tendon	tissues,	our	in	vivo	and	in	vitro	
investigations convincingly prove that Tnmd is a positive regula-
tor	of	cell	proliferation	and	its	loss	accelerates	apoptosis,	which	in	
turn leads to propagation of IVD aging and degenerative process. 
However,	our	study	is	impeded	in	providing	an	explanation	of	the	
exact molecular mode of action of Tnmd,	 due	 to	 lack	 of	 known	
binding	partners.	Therefore,	further	studies	are	promptly	required	
to determine the signaling pathways in which Tnmd participates 
during IVD homeostasis.
Taken	 together,	 our	 findings	 provide	 new	 insights	 into	 the	
protective role of Tnmd in IVD degeneration. Understanding the 
precise Tnmd-dependent	mechanisms	can	 form	the	basis	of	devel-
oping new therapeutic strategies for prevention or treatment of IVD 
degeneration.
4  | E XPERIMENTAL PROCEDURES
4.1 | Animals
Tnmd−/−,	Tnmd−/−Chm1−/−,	and	their	WT	littermates	mice	were	used	in	
this study. The generation of the Tnmd−/−,	Tnmd−/−Chm1−/−	mice,	and	
their primary phenotype tendon tissues and cells were described 
by	Docheva	and	co-workers	(Alberton	et	al.,	2015;	Dex	et	al.,	2017;	
Docheva	et	al.,	2005;	Lin	et	al.,	2017).	All	the	mice	were	backcrossed	
to	a	C57BL/6J	strain.
4.2 | Human samples
Samples	 comprising	 5	 IVDs	 (Table	 S1)	 were	 collected	 from	 5	 pa-
tients undergoing vertebral reconstruction (IVD tissues are re-
moved	 and	discarded)	 due	 to	 burst	 fractures	 or	 lumbar	 tumors	 in	
the	Orthopaedic	Center	of	People's	Liberation	Army,	the	Affiliated	
Southeast	Hospital	of	Xiamen	University.	There	were	3	males	and	2	
females	 (21–32	years	of	age).	All	patients	 received	magnetic	 reso-
nance imaging scans to confirm intact and healthy status of the 
IVDs.	 Samples	 were	 fixed	 immediately	 after	 removal	 in	 4%	 para-
formaldehyde	 (PFA;	Merck)	 overnight	 at	 4°C	 and	 then	 embedded	
in	paraffin.	From	each	patient,	an	 informed	consent	was	obtained.	
Sample	collection	and	experimental	methods	were	authorized	by	the	
Ethics Committee of the Xiamen University.
4.3 | Cell culture
Mouse	OAF	cells	were	 isolated	according	 to	Nakamichi	 and	 col-
leagues	(Nakamichi	et	al.,	2016).	Briefly,	Tnmd−/−	or	WT	mice	were	
euthanized	 and	 lumbar	 discs	 (12-month-old,	 L1/2-5/6,	 6	 animals	
per	 group)	 were	 dissected	 under	 laminar	 flow.	 The	 discs	 were	
trimmed,	and	pieces	of	OAF	tissues	were	obtained,	then	enzymati-
cally	 treated	 overnight	with	 0.04%	 collagenase	 II	 (Worthington)	
in	Dulbecco's	modified	Eagle's	medium	(DMEM)/Ham's	F-12	(1:1)	
(Biochrom)	 supplemented	 with	 10%	 fetal	 bovine	 serum	 (FBS)	
(Sigma-Aldrich)	 and	 1%	 penicillin/streptomycin	 (PS)	 (Biochrom).	
Cell	 suspension	 was	 filtered	 through	 70-µm	 nylon	 mesh	 (VWR	
International)	 and	 centrifuged	 at	 500	 g	 for	 5	min.	 Isolated	 cells	
were	 grown	 in	 DMEM/Ham's	 F-12	 (1:1)	 with	 10%	 FBS,	 1%	
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l-ascorbic-acid-2-phosphate	 (Sigma-Aldrich),	 1%	minimum	 essen-
tial	medium	(MEM)-amino	acid	(Biochrom),	and	1%	PS	until	day	5,	
at which point the medium was changed for the first time. Cells be-
tween	passages	1–3	were	used	for	experiments.	HUVECs	(Lonza)	
were	 cultured	 in	 the	 endothelial	 cell	 growth	medium	 2	 (ECGM-
2)	(PromoCell).	Cells	 in	passages	7–8	were	used	for	experiments.	
Both	cell	types	were	cultured	at	37°C	and	5%	CO2,	kept	up	to	70%	
confluency and supplemented with fresh culture media every third 
day.
4.4 | Histology, immunohistology, and 
histomorphometry
Mouse	 spines	were	 obtained	 after	 euthanasia	 (newborn,	 15	 days,	
1	month,	12	months,	and	18	months	of	age:	n = 3 animals; 6 months 
of age: n	=	5	animals).	The	samples	were	fixed	in	4%	PFA	overnight	at	
4°C.	Following	fixation,	specimens	were	decalcified	in	10%	ethylene	
diamine	tetraacetic	acid	(EDTA)/phosphate-buffered	saline	(PBS)	pH	
8.0	 (Sigma-Aldrich,	Munich,	Germany)	 for	14	days,	 and	embedded	
into	paraffin	or	 cryo-media,	 and	 then	 the	mouse	and	human	sam-
ples were sectioned with 6 μm	(paraffin)	or	10	μm	(cryo),	and	stained	
with	H&E	and	safranin	O	using	standard	protocols.	Quantification	of	
histological	score	was	based	on	a	new	scoring	system	specialized	on	
histomorphology	of	mouse	IVD	(Tam	et	al.,	2018).	In	brief,	the	scor-
ing	system	included	the	following	evaluation:	NP	structure	(0	point,	
single-cell	mass;	1	point,	 cell	 clusters	˂50%;	2	points,	 cell	 clusters	
˃50%;	3	points,	matrix-rich	with	little	cells	NP;	4	points,	mineralized	
NP),	NP	clefts/fissures	(0	point,	none;	+1	point,	mild;	+2	points,	se-
vere),	AF/NP	boundary	(0	point,	clear	cut	boundary;	1	point,	round	
chondrocyte	cells	at	the	boundary;	2	points,	 loss	of	boundary),	AF	
structure	 (0	 point,	 concentric	 lamellar	 structure;	 1	 point,	 serpen-
tine,	widened	or	 rounded	AF	 lamellae;	2	points,	 reversal	of	 lamel-
lae;	3	points,	undefinable	lamellar	structure	or	penetrating	the	NP;	4	
points,	mineralized	or	lost	AF),	and	AF	clefts/fissures	(0	point,	none;	
+1	point,	mild;	+2	points,	severe).	Quantification	of	disc	height	index	
was	performed	on	H&E	images	(Masuda	et	al.,	2005).	In	general,	all	
histology,	 immunohistology,	 and	 histomorphometry	 experiments,	
unless	specified	otherwise	in	the	text,	were	reproduced	in	3	sections	
per sample with 5 or 3 samples per group for investigation.
For	 immunofluorescence	 staining,	 the	 sections	 were	 treated	
with	2	mg/ml	hyaluronidase	 (Sigma-Aldrich)	 for	30	min	at	37°C	 in	
order	 to	 increase	antibody	permeability.	After	washing	and	block-
ing	 with	 2%	 bovine	 serum	 albumin/PBS	 (Sigma-Aldrich),	 primary	
antibodies	 against	 Acan	 (Abcam,	 1:100,	 ab36861),	 CD31	 (Abcam,	
1:50,	ab28364),	Chm1	(Santa	Cruz	Biotechnology,	1:200,	sc-33563),	
Col	 I	 (Abcam,	 1:50,	 ab34710),	 Col	 X	 (Abcam,	 1:50,	 ab58632),	
Fmod	 (Abcam,	1:200,	 ab81443),	 Fn	 (Abcam,	1:50,	 ab2413),	 F4/80	
(Abcam,	1:100,	ab100790),	Lum	(Abcam,	1:50,	ab168348),	MMP-3	
(Novus	Biologicals,	1:100,	NB110-57221),	MMP-9	(Millipore,	1:100,	
AB19016),	Opn	(Abcam,	1:200,	ab8448),	PCNA	(Invitrogen,	1:100,	
13-3900),	 p53	 (Abcam,	 1:100,	 ab61241),	 p65	 (Abcam,	 1:1000,	
ab16502),	 Runx2	 (Abcam,	 1:200,	 ab102711),	 Sox9	 (Abcam,	 1:400,	
ab3697),	 and	 Tnmd	 (Metabion,	 PAB	 201603-00002,	 1:100)	 were	
applied	overnight	at	4°C.	Corresponding	Alexa	Fluor	488-	or	546-la-
beled	secondary	antibodies	(all	from	Life	technology)	were	used	for	
1h	at	room	temperature.	Then,	sections	were	shortly	counter-stained	
with	via	4′,6-diamidino-2-phenylindole	(DAPI)	(Life	technology)	and	
mounted	 with	 fluoroshield	 (Sigma-Aldrich).	 To	 analyze	 apoptotic	
cells	 numbers,	 TUNEL	 kit	 was	 applied	 following	 the	 manufactur-
er's	 instructions	 (Abcam,	 ab66110).	 Photomicrographs	were	 taken	
on	the	Observer	Z1	microscope	equipped	with	the	Axiocam	MRm	
camera	 (Carl	 Zeiss).	 Quantitative	 histomorphometry	 was	 carried	
out	via	an	automated	quantitative	image	analysis	according	to	algo-
rithms	from	literature	(Hsieh	et	al.,	2016;	Lin	et	al.,	2017).	 In	brief,	
using	ImageJ	(National	Institutes	of	Health),	the	following	algorithm	
was	applied:	(a)	area	of	interest	was	manually	designated	using	the	
“drawing/selection”	tool;	(b)	“set	measurements”	for	area,	integrated	
density	and	mean	gray	value	was	selected	from	the	analyze	menu;	
and	(c)	 lastly,	the	corrected	total	cryosections	fluorescence	(CTCF)	
representing	the	Acan,	Col	I,	Col	X,	Fmod,	Fn,	Lum,	MMP3,	MMP-
9,	p65,	and	Tnmd	expression	were	exported	and	calculated	in	Excel	
(Microsoft)	as	follows	CTCF	=	media	of	integrated	density	−	(media	
of	 area	 of	 selected	 area	 ×	mean	 fluorescence).	 To	 analyze	 Chm1-
positive	ratio	of	IVD,	automatic	color	pixel	quantification	tool	in	the	
Adobe	Photoshop	CS5	software	 (Adobe	System)	was	calculated	 in	
percentage	to	the	image	total	pixel	size.	For	IHC	of	the	human	IVDs,	
sections	were	deparaffinized	in	xylene,	dehydrated	in	ethanol,	and	
incubated	with	 0.3%	 hydrogen	 peroxide	 in	 absolute	methanol	 for	
30 min at room temperature to inhibit endogenous peroxidase. To 
enhance	 the	 immunoreactivity	 toward	 TNMD,	 the	 sections	 were	
treated	with	0.05%	citraconic	anhydride	(Sigma-Aldrich)	 in	PBS	for	
30	 min	 at	 60ºϹ.	 After	 washing	 with	 Tris-HCl	 buffer	 (50	 mmol/L	
Tris-HCl,	 pH	 7.6),	 the	 sections	 were	 incubated	 with	 primary	 anti-
body	 (Anti-TNMD	 antibody,	 Sigma-Aldrich,	 1:100,	HPA034961)	 at	
4°C	 overnight,	 followed	 by	 corresponding	 biotinylated	 secondary	
antibody	and	horseradish	peroxidase-labeled	streptavidin.	The	col-
ored	 reaction	 product	 was	 developed	 with	 3,3′-diaminobenzidine	
tetrahydrochloride.	Finally,	the	sections	were	counter-stained	with	
hematoxylin.	For	quantification	of	 the	TNMD-positive	area,	 image	
analysis	of	 the	OAF	or	NP	areas	stained	 in	brown	was	carried	out	
using	ImageJ	(TNMD-positive	area/per	area	of	interest	[%]).
4.5 | IT-AFM
Indentation-type	atomic	force	microscopy	was	performed	on	14	μm-
thick	frozen	tissue	sections	from	6-month-old	Tnmd−/−	and	WT	mice	
(3	animals	per	group;	each	animal	represented	by	3	tissue	sections).	
Measurements	were	taken	with	NanoWizard	AFM	instrument	(JPK	
Instruments)	mounted	on	an	inverted	optical	microscope	(Axiovert	
200,	Zeiss)	as	described	in	detail	previously	(Dex	et	al.,	2017;	Gronau	
et	al.,	2017;	Kamper	et	al.,	2016).	Briefly,	625	indentation	curves	per	
sample were recorded in 2 × 2 μm2 area using pyramidal tips with 
nominal	 radius	of	20	nm	and	 silicon	nitride	 cantilevers	 (MLCT	mi-
crocantilever,	 Bruker).	 The	 spring	 constant	 of	 each	 cantilever	was	
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determined	prior	to	the	experiment	using	the	thermal	noise	method,	
and	the	sample	stiffness	was	determined	via	a	modified	Hertz	model	
using	the	JPK	Data	Processing	software	(V4.2.20,	JPK	Instruments),	
as	 described	 in	 detail	 previously	 (Gronau	 et	 al.,	 2017;	 Kamper	 et	
al.,	2016).	Based	on	these	results,	histograms	were	plotted	and	the	
two maxima were identified by fitting a linear combination of two 
Gaussian	functions	using	OriginLab	software	 (version	6).	As	previ-
ously	reported,	the	lower	stiffness	peak	attributes	to	the	proteogly-
can	moiety,	while	the	higher	stiffness	peak	relates	to	collagen	fibrils	
(Gronau	et	al.,	2017;	Kamper	et	al.,	2016).
4.6 | Western blot analysis
Mouse	IVDs	from	WT	(1	and	6	months	of	age)	and	Tnmd−/− (6 months 
of	age)	animals	were	snap-frozen	in	liquid	nitrogen.	Using	a	mortar	
and	pestle,	the	tissue	was	pulverized	and	resuspended	in	8	M	urea,	
50	mM	Tris-HCl	(pH	8.0),	1	mM	dithiothreitol,	and	1	mM	EDTA.	Protein	
(22 μg)	aliquots	were	loaded	on	a	12%	SDS-polyacrylamide	gel	and	
transferred	 to	 Immobilon-p	 transfer	 membrane	 (Merck	Millipore).	
The	membrane	was	blocked	for	90	min	with	5%	Milk/TBS-T	buffer.	
Anti-Tnmd	 (1:500),	 anti-Chm1	 (1:500),	 and	 anti-β-Actin	 (Abcam,	
1:1,000,	ab8227)	antibodies	were	added.	After	overnight	incubation	
with	 the	primary	antibodies	at	4°C,	membranes	were	washed	and	
probed	with	corresponding	horseradish	peroxidase-conjugated	goat	
anti-rabbit	IgG	(Thermo	Fischer	Scientific).	Protein	bands	were	visu-
alized	 using	 SuperSignal	West	Dura	 Extended	Duration	 Substrate	
(Thermo	Fischer	Scientific)	and	film	paper.	Western	blot	was	inde-
pendently reproduced with two separate preparation of IVDs from 
1-	and	6-month-old	Tnmd−/−	and	WT	animals.
4.7 | Semiquantitative and qRT–PCR
Total	 RNAs	 from	OAF	 tissues	 (n	 =	 3	 animals)	 and	OAF	 cells	were	
isolated	with	Qiagen	RNeasy	Mini	kit	 (Qiagen)	and	used	for	stand-
ard	 semiquantitative	 and	 qRT–PCR.	 For	 cDNA	 synthesis,	 1	 μg 
total	 RNA	 and	 AMV	 First-Strand	 cDNA	 Synthesis	 Kit	 (Invitrogen)	
were	implemented.	Semiquantitative	PCR	was	performed	with	Taq	
DNA	 Polymerase	 (Invitrogen)	 in	MGResearch	 instrument	 (BioRad,	
Munich,	Germany).	Primer	sequences	and	PCR	conditions	were	as	
follows: Tnmd	 forward	 5′gaaaccatggcaaagaatcctccagag3′,	 reverse	
5′ttagactctcccaagcatgcgggc3′;	 Chm1	 forward	 5′atggtagggcctgag-
gacgttg3′,	reverse	5′gctgcatggcatgacgactctg3′;	Gapdh	forward	5′ga-
gaggccctatcccaactc3′,	 reverse	 5′gtgggtgcagcgaactttat3′;	 PCR	 was	
performed	with	incubation	at	94°C	for	5	min	followed	by	30	cycles	
of	a	three-step	temperature	program	of	1	min	at	94°C,	20	s	at	57°C,	
and	30	s	at	72°C.	The	PCR	reaction	was	 terminated	after	a	7	min	
extension	 at	 70°C.	 The	 band	 intensity	 of	 the	 amplified	 products	
in	 the	 gel	was	 visualized,	 photographed,	 and	 analyzed	 using	 a	 gel	
imager	 (Vilber	Lourmat).	The	 relative	gene	expression	was	quanti-
fied	by	densitometry	and	normalized	to	the	amount	of	Gapdh with 
ImageJ	 and	presented	as	 fold	 change	 to	WT.	Quantitative	PCR	of	
tendon-associated	 genes	 was	 performed	 using	 RealTime	 Ready	
Custom	Panel	 96	 –	 32+	 plates	 (https	://confi	gurat	or.realt	imere	ady.
roche.com)	 according	 to	 the	 manufacturer's	 instructions	 (Roche	
Applied	 Science).	 Briefly,	 PCR	 reactions	were	 pipetted	 on	 ice	 and	
each	well	contained	10	µl	LightCycler	480	probes	master	mix,	0.2	µl	
cDNA	(diluted	1:5)	and	9.8	µl	PCR	grade	water.	Plates	were	subse-
quently	 sealed	 and	 centrifuged	 down	 for	 15	 s.	 at	 2,100	 rpm.	 The	
relative gene expression was calculated as a ratio to Gapdh.	All	PCR	
results have been reproduced in three independent experiments.
4.8 | Migration analysis
Migration analysis was performed similarly to our previous 
study	 (Popov,	 Kohler,	 &	 Docheva,	 2016).	 For	 random	 migration,	
1.5 × 103 cells/cm2 of Tnmd−/−	 and	WT	OAF	cells	were	seeded	on	
Col	 I-coated	 (20	μg/Ml;	Millipore)	 6-well	 plates	 and	 incubated	 for	
2 hr prior imaging. Time lapse was performed with 4 frames per 
20	min	for	24	hr.	The	image	data	were	extracted	with	AxioVisionLE	
software	(Carl	Zeiss),	and	individual	cell	tracks	were	analyzed	with	
ImageJ.	Random	migration	was	expressed	by	calculation	of	the	for-
ward	migration	index	(FMI;	the	ratio	of	the	vector	length	to	the	mi-
gratory	starting	point),	velocity,	and	accumulated	(cumulative	track	
length)	and	Euclidian	(the	ordinary	straight-line	length	between	two	
points)	distances.	Results	of	random	OAF	cells	migration	measure-
ments	consist	of	3	 independent	 time-lapse	movies	of	 two	Tnmd−/− 
and	WT	OAF	cells	donors	as	a	total	number	of	20–25	OAF	cells	per	
genotype were tracked.
4.9 | CyQUANT assays
A	total	of	1.5	×	103	cells	(passage	1)	per	well	were	plated	in	6-well	
plates,	and	CyQUANT	assay	detection	was	performed	according	to	
the	manufacturer's	instructions	(Invitrogen)	after	0,	3,	5,	and	7	days	
cell	culture.	CyQUANT	assay	was	repeated	 independently	 in	3	ex-
periments per time point.
4.10 | HUVECs-OAF cells co-culture
Co-cultures	 were	 performed	 using	 Boyden	 chambers	 with	 mem-
brane	 containing	 8.0	 μm	pores	 inserted	 in	 24-well	 plates	 (Becton	
Dickinson	Labware)	as	described	previously	(Kimura	et	al.,	2008).	In	
brief,	Tnmd−/−	or	WT	OAF	cells	(1	×	104	cells	per	well)	were	seeded	on	
the	bottom	of	the	wells	and	cultured	in	DMEM/Ham's	F-12	(1:1)	with	
10%	FBS,	1%	l-ascorbic-acid-2-phosphate,	1%	MEM-amino	acid,	and	
1%	PS	for	24	hr,	and	then,	the	medium	was	replaced	with	ECGM-2.	
Before	seeding	HUVECs	into	the	upper	chamber,	the	membrane	was	
coated with Col I (10 μg/Ml;	Millipore),	 kept	 in	 a	 humidified	 incu-
bator	overnight,	 and	 filled	with	ECGM-2	an	hour	before	 introduc-
ing the 5 × 103	HUVECs	per	well.	After	36	hr	co-culturing,	HUVECs	
that have migrated through the pores and adhered to the lower side 
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of	 the	membrane	were	 fixed	with	4%	PFA	and	stained	with	DAPI.	
The	 cell	 nuclei	 were	 counted	 using	 the	 Observer	 Z1	 microscope	
equipped	with	the	Axiocam	MRm	camera.	Tnmd−/−	or	WT	OAF	cells	
in	the	lower	chamber	were	analyzed	for	p65,	MMP-3,	and	MMP-9	
by	immunofluorescence	staining.	The	interactions	of	the	co-cultures	
assays	were	repeated	independently	in	3	experiments.	All	cell	nuclei	
(DAPI)	in	3	images	per	well	from	5	wells	per	plate	were	counted.
4.11 | Statistical analysis
In	this	study,	each	animal	was	represented	with	3	different	tissue	sec-
tions with comparable planes between genotypes. The results were 
averaged per animal were presented as mean ± SD between the 3–5 
animals per group. Exact animal number and experimental reproduc-
ibility	is	given	for	each	result	in	the	figure	legends.	Statistical	differ-
ences	between	two	groups	were	determined	using	two-tailed	unpaired	
Student's	t	test,	or	two-tailed	nonparametric	Mann–Whitney	test.	In	
multiple	comparisons,	one-way	ANOVA	was	followed	by	Bonferroni	
post hoc correction. Differences were considered statistically signifi-
cant at the values of *p	<	.05,	**p	<	.01,	and	***p < .001.
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